Español
Français
Deutsch
Italiano
Português
TeamUp Strategies
Runway Architecture
Decisive Intelligence
Clinical Informatics
Patient Measurement
Perspectives
Cardiology
Acute Care
Private Clinic
Emergency department
Intensive care unit
Neonatal intensive care unit
Perioperative care
Keeping caregivers safe
Clinical education
UK Pathfinder SL and Lifescreen Pro user training
eLearning
Technical training
Open a support ticket
Product manuals
Service contract
Cleaning instructions
Supplier change request
Contact us
Regional contacts
Our heritage
Senior management
News and Events
Patents and trademarks
Quality and ISO certificates
Careers
Terms and policiesVersatility and performance in new-generation dual-mode patient monitor
SNOQUALMIE, Wash.–Spacelabs® Healthcare announced the release of its DM4 dual-mode monitor (the “DM4”), the newest member of the Company’s patient monitoring line. The DM4 combines the simple performance of a spot-check monitor with the sophistication of continuous monitoring and is designed to provide caregivers with a versatile solution for accurately and efficiently monitoring basic vital signs on adult, pediatric, and neonate patients.
The DM4 is designed for use in any patient care environment where basic vital signs monitoring is needed, and it is expected to enable caregivers to adapt to changes in patient condition without having to locate additional equipment. In spot-check mode, the DM4 can wirelessly transmit individual patient records to an electronic medical record system (EMR), or it can be used to efficiently collect and download multiple patients’ records in batch mode from a central location. If more vigilance is required, the DM4 can be quickly switched to continuous monitoring mode with alarm notification support.
About Spacelabs
Spacelabs, a division of OSI Systems, Inc., is a provider of medical equipment and services, including solutions for patient monitoring and connectivity, diagnostic cardiology, and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, and Singapore, and distributors in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company’s current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company’s control and which may cause actual results to differ materially from those described in or implied by any forward-looking statements. Such statements include, but are not limited to, statements regarding the performance of the Company’s products. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. The Company assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws. For a further discussion of factors that could cause the Company’s future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in the OSI Systems, Inc. Annual Report on Form 10-K for the fiscal year ended June 30, 2018 and other risks described therein and in documents subsequently filed by OSI Systems, Inc. from time to time with the Securities and Exchange Commission.